The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tallquist, M. D.
Right arrow Articles by Pease, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tallquist, M. D.
Right arrow Articles by Pease, L. R.
The Journal of Immunology, 1998, 160: 802-809.
Copyright © 1998 by The American Association of Immunologists

Degenerate Recognition of Alloantigenic Peptides on a Positive-Selecting Class I Molecule1

Michelle D. Tallquist2,*, Arthur J. Weaver{ddagger} and Larry R. Pease3,*,{dagger}

Departments of * Immunology and {dagger} Molecular Biology and Biochemistry, Mayo Clinic, Rochester, MN 55905; and {ddagger} hkl Research, Inc., Rochester, MN 55902


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The well-defined 2C T cell was used to investigate alloreactive degeneracy. A panel of class I molecules that are known ligands for the 2C TCR were sensitized with three known peptide ligands, p2Ca (LSPFPFDL), dEV-8 (EQYKFYSV), and SIYR-8 (SIYRYYGL). The peptide p2Ca was originally identified as the allopeptide seen in the Ld class I molecule by 2C T cells, 2C recognizes the dEV-8 peptide as the ligand in the Kbm3 class I molecule, and SIYR-8 was recently identified as a peptide ligand for 2C in the context of the Kb class I molecule. Strong recognition of all three Ag-presenting molecules occurred in the context of their respective allopeptides, but 2C recognized all three peptides to a measurable extent in the context of Kb. Molecular modeling of these Kb/peptide complexes revealed a high degree of similarity between dEV-8 and SIYR-8, but very little conformational similarity of either of these peptides with p2Ca. Furthermore, the structural changes in the mutant Kbm3 binding site resulted in generalized changes in the conformation of each of five bound peptides compared with those of the same peptides bound to Kb. The finding that degenerate recognition occurs on Kb, the restriction element responsible for selecting 2C T cells, suggests a unique relationship between a TCR and the Ag-presenting molecule that mediates its positive selection.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
TCRs bind antigenic peptide fragments only in the context of MHC molecules. Over the past several years the molecular interactions that are required for TCR activation have been delineated, and several examples of degenerate recognition have been observed. These examples range from those involved in positive and negative selection (1, 2), allorecognition (3, 4, 5), and functional activation (6, 7). The reasons and significance for this degenerate recognition are unclear. It is possible that the very nature of TCR recognition encourages a degree of promiscuous interactions. T cells must recognize self molecules during positive selection and then interact with foreign Ags during infection. A productive TCR/MHC interaction is a result of a relatively low affinity of the TCR for MHC/peptide complexes (8, 9), as determined by only a few accessible peptide side chains (10, 11). Consequently, more than one peptide could provide the necessary contacts for a productive interaction with a single TCR.

To address the issue of TCR degeneracy, we investigated MHC/peptide complexes found to be antigenic for the 2C T cell. The alloreactive 2C T cell recognizes Ld and Kbm3 murine class I molecules as alloantigens (12, 13), and the respective allopeptides, p2Ca and dEV-8, have been identified (5, 14). In addition, a third peptide, SIYR-8, has been identified from a degenerate synthetic peptide library, which is antigenic for the 2C T cell in the context of the Kb class I molecule (15). The addition of this third peptide to the set of peptide Ags strongly recognized by 2C is interesting because experiments with 2C TCR transgenic mice have revealed that the Kb class I molecule is necessary for positively selecting the 2C TCR (16). As 2C can bind a set of different MHC/peptide targets, we were interested in the specificities exhibited toward various combinations of peptide with the three MHC molecules. We found a degenerate recognition by 2C of all three peptides when presented in the context of the self-restricting element, Kb.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cell lines

T2 cells were transfected with Kb/Ld and Kbm3/Ld, respectively, using constructs described previously (17). T2 cells were provided by Dr. L. Sherman (The Scripps Institute, La Jolla, CA), T2Ld cells were supplied by Dr. P. Cresswell (Yale University, New Haven, CT), and RMA-S cells were provided by Dr. T. Hansen (Washington University, St. Louis, MO). T2 transfectants were maintained in 500 µg/ml G418.

Peptides

Peptides were synthesized using solid phase chemistry as described previously with F-moc-protected L amino acids (18). Each synthetic peptide was purified to a single homogeneous peak by reverse phase HPLC (see Table IGo for peptide sequences).


View this table:
[in this window]
[in a new window]
 
Table I. Peptides used in this study1

 
Cytotoxicity assays

CTLs used in this study were either lines established from 2C transgenic mice (16) or the original 2C CTL clone (12) provided by D. M. Kranz (University of Illinois, Urbana, IL). Briefly, splenocytes from the transgenic mice or the 2C clone (DK) were stimulated weekly with lethally irradiated BALB/c stimulators in the presence of rat Con A supernatant and rIL-2. A standard 5-h 51Cr release assay with 3 x 103 targets/well was employed. When peptide was added, targets were incubated with synthetic peptides for 0.5 to 1 h before the addition of effector cells. In the case of experiments using SIYR-8, targets were extensively washed before the addition of effector cells to avoid presentation of SIYR-8 by T cells. The percent specific lysis was calculated as follows: [(experimental lysis - spontaneous lysis)/(maximum release - spontaneous lysis)] x 100.

Flow cytometric analysis by conformational sensitive Abs

T2-Kb/Ld cells (5–7 x 105) were incubated with 10 µM of the indicated peptide at 37°C for 3 h. Cells were then washed and incubated with mAbs in culture supernatant, except 100.3 and 5F1.2-14, which were ascites. The mAb 28-14-8S (American Type Culture Collection, Rockville, MD) is specific for the {alpha}3 domain of the chimeric Kb/Ld molecule and served as an indicator of surface expression that was independent of peptide changes in the {alpha}1-{alpha}2 regions. The mAbs used were K10.56 (19), 28-13-3 (American Type Culture Collection), 100.3 (provided by K. Hogquist, University of Minnesota, St. Paul, MN), and 5F1.2-14 (provided by P. Wettstein, Mayo Clinic, Rochester, MN). Detection of Abs was performed with FITC-goat anti-mouse IgG (Biosource International, Camarillo, CA). Flow cytometry was performed on a FACScan (Becton Dickinson, Mountain View, CA), and mean channel fluorescence (MCF)4 values were obtained. Correction of mean channel differences was calculated as follows: corrected mean channel difference = MCF peptide-pulsed mAb - MCF-unpulsed mAb + MCF peptide-pulsed 28-14-8 - MCF-unpulsed 28-14-8. The corrected value represents the change in conformation after changes in levels of surface expression have been taken into consideration.

RMA-S stabilization

RMA-S cells (2 x 105) were incubated at 26°C with the indicated concentrations of peptide for 7 h and then moved to 37°C for 3 h. Cells were then washed and stained for Kb expression with the primary Ab B8-24-3 (American Type Culture Collection) and an FITC-conjugated goat anti-mouse Fab' secondary Ab (Biosource International, Camarillo, CA).

Molecular modeling

Starting atomic coordinates for molecular modeling were obtained from three MHC class I H-2Kb structures in the Brookhaven Protein Data Bank with identification codes 1VAA (10), 1VAB (10), and 1VAC (11). The 1VAA structure complexed with an eight-residue vesicular stomatitis virus peptide (Kb:VSV-8) was mutated using the program O (20) to generate starting coordinates for both the H-2Kbm3+peptide structures (Kb:dEV-8, Kb:p2Ca, Kb:SIYR-8) and the H-2Kbm3+peptide structures (Kbm3:dEV-8, Kbm3:p2Ca, Kbm3:SIYR-8). In all cases, the most frequently occurring side chain rotamer in the O database (21) was selected as the starting side chain conformation for the mutated residues.

The starting coordinates for each system were then used in the program X-PLOR 3.1 (22) for energy minimization and molecular dynamics. Coordinates were modified in X-PLOR to remove residues 181 to 274 of the A chain ({alpha}3 domain), ß2m, and all crystallographically defined water molecules not within 3 Å of residues 1 to 180 ({alpha}1 and {alpha}2 domains). The resulting system was centered in a box of 60 Å x 40 Å x 60 Å with P1 symmetry. Polar hydrogens were then added to the protein and peptide consistent with the use of standard crystallographic force-field parameters (23) as implemented within the X-PLOR program. To completely solvate the system, additional water molecules were systematically added by translation of a pre-equilibrated smaller box of 125 water molecules to fill the simulation box excluding a region within 3 Å of the protein surface. The final systems contained approximately 11,400 atoms, including about 3,200 water molecules (9,600 atoms).

The X-PLOR-modified coordinates were subjected to 150 cycles of Powell energy minimization followed by a molecular dynamics step and a final 150 cycles of energy minimization. Molecular dynamics was conducted using a simulated annealing protocol with an integration time of 0.2 ps (400 0.5-fs steps) at each of 18 temperature steps of -100°K between a starting temperature of 2000°K and a final temperature of 300°K. All energy minimization and molecular dynamics steps were conducted within X-PLOR using coordinate-based shake constraints for protein and peptide hydrogens and parameter-based shake constraints for water molecules (22). Additional mild harmonic restraints were imposed on the A chain to compensate for removal of the {alpha}3 and ß2m domains, and, more importantly, to provide realistic restraints to molecular motion consistent with the known crystal structures. Averaged rmsd values for A chain residues were calculated a priori using X-PLOR for pairwise least squares superpositions of the three H-2Kb structures in the PDB (1VAA, 1VAB, and 1VAC). The average rmsd was 0.181 Å for A chain backbone atoms and 0.552 Å for A chain side chain atoms for these three structures. For each simulation, a harmonic restraint coefficient for a given A chain residue was set to the average backbone rmsd (0.181) divided by the rmsd for backbone atoms of that residue, and similarly to the average rmsd (0.552) divided by the rmsd for side chain atoms of the residue. Examination of the molecular dynamics trajectories showed that such restraints allowed more motion in protein loops than in regions of well-defined secondary structure. Each simulation required approximately 14 h of computational time on a Silicon Graphics Indigo-2 R4400 (150 MHz) machine (Silicon Graphics, Mountainview, CA).

Final coordinate sets obtained after simulated annealing and energy minimization were compared using X-PLOR by least squares minimization of protein backbone atom (N, CA, C, O) distances for residues 1 to 180 of the {alpha}1 and {alpha}2 domains. Peptide atoms and mutated residues (positions 77 and 89) were not included in least squares calculations.

After least squares superposition of paired coordinate sets, atomic displacements were calculated using a UNIX command file script devised for that purpose and then mapped to a molecular surface rendered with the program GRASP (24). Molecular surface displacement of superposed structures was calculated and displayed using GRASP. Atom-by-atom solvent-accessible surface areas were calculated in GRASP using a probe radius of 1.4 Å; difference calculations were made using a UNIX command file script and then displayed using GRASP. Electrostatic potential maps were calculated and displayed using GRASP, assuming a salt concentration of 0.1 M.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
2C recognition of peptides in Kb is degenerate

Recently, several antigenic peptides have been defined for the alloreactive 2C TCR (see Table IGo). To evaluate the level of degeneracy of 2C recognition, we tested the panel of peptides in the context of two class I molecules that are alloantigens for the 2C TCR and also in the context of the self-restriction element for 2C, Kb (see Table IIGo and Fig. 1Go). As previously known, the Ld allopeptide, p2Ca, was antigenic when presented to 2C cells by Ld or Kb (9, 14, 25), but not by Kbm3 (26). In the present analysis the Kbm3 allopeptide dEV-8 was recognized in the context of both Kb and Kbm3, but not Ld. The peptide SIYR-8, which has defined antigenicity when presented by the Kb molecule (15), was not seen by 2C in our study when presented by Ld-bearing cells (Table IIGo), but was recognized when presented by Kbm3 (Table IIIGo). Thus, the 2C TCR recognition of peptide Ags was specific in the context of the alloantigens Ld, but degenerate in the recognition of all three peptides when presented by the self-restricting element, Kb. Other peptides, such as mLBP, OVA-8, and a library of unrelated peptides derived from known Kb binding peptides (27), were not recognized by 2C, even when presented at a 5-µM concentration by TAP-deficient APC. This (data not shown) indicates that there is a high level of peptide specificity in 2C recognition of Kb.


View this table:
[in this window]
[in a new window]
 
Table II. Peptide specificity for 2C T cell recognition of alloantigens1

 


View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 1. The dEV-8- and p2Ca-induced lysis of T2Kb targets by 2C effector cells. T2-Kb cells were incubated with peptide 30 min before the addition of effector cells. Effector cells were 2C transgenic T cell clones 5 days after stimulation. The E:T ratio was 2:1. Data are representative of at least five independent experiments. Similar data were generated with the original 2C T cell line (designated DK) at an E:T ratio of 24:1 (data not shown). No specific lysis was observed when the irrelevant peptides OVA-8 and mlBP were added to T2Kb cells at 5-µM concentrations.

 

View this table:
[in this window]
[in a new window]
 
Table III. Recognition of T2-Kbm3: SIYR-8 by 2C1

 
RMA-S stabilization by the panel of peptides

We next chose to compare the binding efficiency of each peptide for the Kb molecule using an RMA-S stabilization assay (Fig. 2Go). The antigenic SIYR-8 stabilized the surface expression of Kb as efficiently as the strong Kb-restricted peptide Ag OVA-8. The two more weakly antigenic peptides, p2Ca and dEV-8, were less efficient at stabilizing Kb in this assay. The nonantigenic peptide, mLBP, stabilized Kb intermediately. Significantly, all peptides were capable of binding and stabilizing Kb, a finding consistent with ability of 2C to recognize three of the peptides when presented by Kb. The inability of 2C cells to lyse targets bearing the mLBP or OVA peptides is not due to the inability of the peptides to bind the Ag-presenting molecule. The increased peptide concentrations required for recognition of dEV-8 and p2Ca in Kb appears to be related at least in part to lower peptide binding affinities. However, judging from the similar quantities of endogenous dEV-8 recoverable from immunoaffinity-purified Kb and Kbm3 isolated from cells (26), the quantitative differences in recognition of Kb:dEV-8 and Kbm3:dEV-8 are not directly related to differences in peptide:MHC binding.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 2. RMA-S stabilization assay. Peptide titrations on RMA-S cells were accomplished using the conformation-insensitive Ab, B8.24-3, as described in Materials and Methods. The MCF indicates the intensity above background (no peptide addition).

 
Conformation of Kb and Kbm3 molecules

The differences in fine specificity in the recognition by 2C of the peptides presented in the context of Kb or Kbm3 led us to compare the surfaces of the MHC/peptide complexes with conformation-sensitive Abs. These Abs bind Kb differentially depending on the structure of the peptides bound or as a consequence of amino acid substitutions on the floor of the class I peptide binding site (28, 29). Consequently, Ab can be used as a measurement of surface structure when a particular peptide is bound. The Ab binding measurements were normalized by subtracting the increase in surface epitope expression induced by peptide addition, as determined by mAb 28-14-8, from the values determined for binding of specific, conformationally dependent Abs. An example of the fluorescence shift is illustrated in Figure 3Go. Only one Ab, 28-13-3, did not bind Kbm3 as efficiently as it bound Kb when no peptide was added (Table IVGo). Two inferences can be made from these data. The first comes from directly comparing the conformation-sensitive Ab binding across the panel of peptides. Comparisons that revealed increases or decreases within 50 channels were judged to be similar. When bound to the Kb molecule, dEV-8 and SIYR-8 induced conformations that were recognized similarly by three of the four Abs (K10.56, 28-13-3, and 100.3). Only 5F1.2.14 was able to distinguish between the two bound peptides. Peptide p2Ca, compared with SIYR-8 or dEV-8, had similar binding profiles for two of the four Abs (K10.56 and 28-13-3). Both 5F1.2.14 and 100.3 differentially bound the p2Ca-Kb complex relative to dEV8-Kb or SIYR-8-Kb. This suggests that the structure of p2Ca in Kb is less similar to dEV-8 than is the structure of SIYR-8. When looking at the effects of the binding of other peptides on Ab epitopes expressed by Kb and Kbm3, it was evident that there was a wide range of conformational changes induced by the peptides, and that some peptides had very dramatic influences on the conformational structure of the class I molecules. For example, OVA altered the structures of three of the four Abs substantially in the case of Kb and of all four Abs in the case of Kbm3.



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 3. Peptide-induced conformational changes. Example of fluorescence shift for the 5F1.2.14 Ab when a 10-µM concentration of the dEV-8 peptide was added to T2 cells expressing Kb or Kbm3. The filled histogram shows class I expression with peptide added; the outlined histogram shows class I expression without peptide.

 

View this table:
[in this window]
[in a new window]
 
Table IV. Peptide-induced conformational differences1

 
Table IVGo further illustrates that the epitope profiles of Kb and Kbm3 vary differentially as a consequence of binding to a broader set of five peptides. This is evident upon comparison of the relative magnitude and direction of change in Ab binding when each of the five peptides is bound to Kb or Kbm3 (compare the boldface values in Table IVGo). No peptide generated the same profile when bound to Kb and Kbm3. This leads to the conclusion that a major consequence of the amino acid substitution at position 77 in Kbm3 is to change the pattern of conformations of the Ab-accessible surface in a peptide-dependent manner. The implication of this finding is that the peptides may induce similar structural changes at the molecular surface that influence TCR recognition. As all five peptides induce different epitope profiles, it is reasonable to consider the possibility that such differences are widespread among both self and non-self peptides bound and presented to T cells by Kb and Kbm3. However, it is important to point out that these structural differences observed using mAbs do not necessarily correlate with the binding patterns of specific TCR as 2C recognizes SIYR-8 efficiently in the context of both Kb and Kbm3 (more differences in Ab binding) and differentially when dEV-8 is presented by both molecules (fewer mAb binding differences). Similarly, the extensive Ab epitope differences (four of four mAbs in Table IVGo) observed in the comparison of Kb-OVA and Kbm3-OVA are reflected by the differential recognition T cell lines to recognize OVA-pulsed Kbm3 target cells (30).

Molecular models of peptides

Because the primary sequences of these peptides do not provide direct information about the tertiary structure of the peptides when they are complexed with Kb, and no crystal structure of Kb is available with the three peptides of interest, we generated a model of each peptide in the Kb groove using a published crystal structures for the Kb:VSV-8 peptide complex (10) as a reference structure. The amino acid residues for the VSV peptide from the Kb:VSV-8 crystal structure were replaced with the corresponding residues of the three peptides, dEV-8, SIYR-8, and p2Ca. The modified structures were then subjected to energy minimization and molecular dynamics. The interactions with ß2m were not included in the simulation. However, restraints on the movement of atoms in the Kb heavy chain were introduced to simulate the contribution of ß2m and other unknown determinants of class I structure. We reasoned that important restraints would be reflected in conserved similarities between known structures of Kb as the molecule is bound to different peptides. Three such structures have been solved (10, 11). Imposed movement restraints for each atom were inversely proportional to the least squares rmsd deviation values calculated from the three sets of coordinates for the Kb crystals (see Materials and Methods). Similar models could not be conducted of Ld, as no structural coordinates have been reported.

The dEV-8 and SIYR-8 peptides exhibit similar predicted conformations in the Kb class I molecule

The predicted conformations of the dEV-8 and SIYR-8 peptides, both antigenic in the context of Kb, are surprisingly similar (Fig. 4GoA). The positions of the peptide backbone atoms are nearly identical (rmsd = 0.534 Å, compared with an rmsd of 0.657 Å for the unmodified Kb:VSV-8 structure subjected to the same manipulations). The aromatic side chain residues at P3, P5, and P6 have very similar, overlapping conformations within the binding groove. Even the positively charged side chain at P4 (Lys, dEV-8; Arg, SIYR-8) is pointing up out of the groove in a similar manner. The remaining side chains at P1, P2, P7, and P8 also have very similar conformations when considering the differences between the residues. After comparing these two peptides modeled into the Kb molecule, it is not difficult to appreciate the fact that they are both seen similarly by the 2C TCR and our panel of mAbs. Nonetheless, some of the modest differences between the two peptides and interacting heavy chain regions must contribute to the significant quantitative differences in the ability of the 2C T cell to respond to the two different peptides when bound to Kb.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 4. Comparison of peptide orientations after simulated annealing, energy minimization, and least squares superposition (see Materials and Methods) for Kb:SIYR-8 (A; light bonds), Kb:dEV-8 (A; dark bonds), Kb:SIYR-8 (B; light bonds), and Kb:p2Ca (B; dark bonds). The centrally positioned tyrosine ring of SIYR and the phenylalanine ring of dEV8 project downward into pocket C. Peptides are shown side-on, with the N-terminus on the left, the binding groove at the bottom, and the TCR binding surface at the top. The rmsd of the peptide backbone atoms is 0.534 Å in A and 0.798 Å in B. The rmsd for peptide side chain atoms is not calculable due to differing amino acid sequences.

 
Noncanonical binding of p2Ca in the Kb class I molecule

In contrast to the similarity of conformation of dEV-8 and SIYR-8, is the dissimilarity of the p2Ca conformation (Fig. 4GoB). When p2Ca was modeled into the Kb molecule, the positional changes in the peptide backbone atoms were greater (rmsd = 0.798 Å). The first point to note is that p2Ca does not have an aromatic residue positioned in pocket C. (Note the proline ring at the center of p2Ca in place of the tyrosine ring that projects down into pocket C.) This position is commonly a strong anchor position for the Kb molecule (31). Another dramatic difference between p2Ca and dEV-8 or SIYR-8 is the lack of Tyr at P3. P3 is a proposed secondary anchor position that interacts with pocket D (32). Despite these major differences, some minor similarities can be observed between p2Ca conformation and the conformation of the other two 2C antigenic peptides. As illustrated in Figure 4GoB, the most obvious similarity is the aromatic residue at P6, which is in a similar orientation to that seen for the analogous amino acid in SIYR-8. The other shared feature, although not as striking, is the amino acid residue at P4. This residue in both peptides is pointing directly out of the groove in a position that would interact with the TCR. Even though the PheP4 of p2Ca does not have the similar charge or shape of dEV-8 (LysP4) or SIYR-8 (ArgP4), it does have the similar planar structure as the ArgP4 in SIYR-8. Aside from these minimal similarities and those at the N-terminus and C-terminus, the p2Ca peptide conformation is very distinct from the SIYR-8 and dEV-8 conformations. Nonetheless, the 2C T cell responds to Kb-expressing cells loaded with p2Ca approximately as well as to cells loaded with dEV-8 (Fig. 1Go).

Structure of peptides when bound to Kbm3

We next sought to appreciate the structural significance of the amino acid replacement at amino acids 77 (Asp to Ser) and 89 (Lys to Ala) in the Kbm3 molecule as they interact with the three peptides. To accomplish this, we remodeled the peptide/heavy chain structures after introducing the bm3 amino acid replacements at positions 77 and 89 in the class I heavy chain. The first insight emanating from the analysis is that the amino acid replacement in the heavy chain has little direct influence on the surface of the class I molecule. As shown in the molecular surfaces of Figure 5Go, there is little perturbation in the positions of surface atoms (Fig. 5GoA), overall surface structure (Fig. 5GoB), or accessible surface (Fig. 5GoC) in the immediate vicinity of amino acid 77. There is, however, some modification of surface electrostatic potential that results from the substitution of the Asp at position 77 (Fig. 5GoD). This is mostly confined to the peptide binding groove beneath the bound peptide, a finding that is consistent with the differential binding of mAb 28-13-3 with peptide-deficient Kb and Kbm3 molecules expressed on transfected T2 cells (Table IVGo). This absence of significant surface perturbation in the presence of bound peptide is consistent with our previously reported finding that amino acid position 77 does not influence Ab epitopes expressed on the surface of normal (TAP-proficient) cells (17). The implication is that the consequences of the substitution are indirect, mediated by interactions with bound peptide. Such indirect conformation changes can only be visualized by Ab staining when a large number of cell surface molecules are bound to a single peptide species, as seen in the case of peptide-pulsed TAP-deficient T2 cells.



View larger version (85K):
[in this window]
[in a new window]
 
FIGURE 5. Molecular surface of Kbm3:SIYR-8 colored according to atomic displacement (A), molecular surface displacement (B), change in solvent-accessible surface area (C), and change in electrostatic potential (D; see Materials and Methods). Color gradation from gray to red to yellow corresponds to displacements of 0.5, 1.5, and 2.5 Å, respectively, for individual atoms (A) or surface elements (B). Color gradation from red to gray to blue in C corresponds to changes in accessible surface area of -20, 0, and +20 Å2, and that in D corresponds to a change in electrostatic potential of -10, 0, and +10 kT, respectively.

 
The modeling experiment indicates that the influence of the bm3 mutation on the peptide structure of dEV-8 is minimal (Fig. 6GoA). The backbone atoms of the peptide as well as the orientation of the side chains are very similar to those seen when the peptide is bound to Kb. The major difference appears to be the orientation of the aromatic ring of the Tyr residue at position 6. This structural similarity is reflected in the similar mAb binding patterns shown in Table IVGo. In contrast, the Kbm3 Asp to Ser substitutions have a more pronounced influence on the structure of the dEV-8 and p2Ca peptides (Fig. 6Go, B and C). These increased differences observed in the models are consistent with the differences seen using Abs to probe the molecular surface of the molecules (Table IVGo). In the case of both dEV-8 and p2Ca bound to Kbm3, the positions of the peptide backbone atoms are displaced significantly for residues 6, 7, and 8, changing the positions of each of the associated side chains.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 6. Comparison of peptide orientations after simulated annealing, energy minimization, and least squares superposition (see Materials and Methods) for Kb:dEV-8 (A; dark bonds), Kbm3:dEV-8 (A; light bonds), KB:SIYR-8 (B; dark bonds), Kbm3:SIYR-8 (B; light bonds), Kb:p2Ca (C; dark bonds), and Kbm3:p2Ca (C; light bonds). Peptides are shown side-on, with the N-terminus on the left, the binding groove at the bottom, and the TCR binding surface at the top. The rmsd of the peptide backbone atoms is 0.650 Å in A, 0.942 Å in B, and 0.917 Å in C. The rmsd of all peptide atoms including side chains is 1.374 Å in A, 1.639 Å in B, and 1.927 Å in C.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although MHC/peptide crystal structures have provided many details about peptide binding and TCR-accessible residues, we still have very limited information involving the TCR recognition of MHC/peptide complexes (33, 34). Recently, two TCRs cocrystallized with class I molecules reveal that the receptor contacts the class I heavy chain complex in a manner similar to how an Ab might bind. Moreover, the fact that both resolved structures share a common orientation suggests that there exists a common docking strategy that dictates which features of class I molecules will influence this process. In this report, we address the degenerative recognition by the 2C TCR of peptides presented by the Kb class I molecule and the high specificity of the recognition pattern when the same peptides are presented by non-self Ag-presenting molecules.

Several interesting points can be drawn from this study. One of the most intriguing is the fact that the 2C TCR can recognize three different peptides in the context of the self-restricting element Kb, albeit with differing levels of efficiency. The peptide SIYR-8 was recognized strongly (15) (our unpublished observations), while dEV-8 and p2Ca were recognized only when presented at high concentration on TAP-deficient cells. It is not clear at this time whether the ability of the 2C TCR to recognize this set of three peptides is fortuitous, or whether the fact that the 2C TCR undergoes positive selection in the context of Kb is related to this reactivity pattern. In support of the latter view, 2C recognition of Ld and Kbm3 did not exhibit the broad range of reactivity.

Molecular modeling revealed surprisingly similar structures in the case of two of the peptides, dEV-8 and SIYR-8, when they are presented by Kb. This view is consistent with the cross-reactivity of the two antigenic structures. However, the structure of the third peptide, p2Ca, appears to be very dissimilar when modeled into the Kb peptide binding site. The conclusion that 2C recognizes distinct structures was reached similarly in a recent study that modeled Kb-SIYR-8 and Ld-p2Ca for comparison of their TCR interactive surfaces (35).

Recently, several laboratories have shown that T cells can recognize minimally homologous peptides in the same class II molecule (6, 7). The distinction between our work and these earlier studies is that they found degeneracy of T cell recognition on only one specific class II molecule, and peptides were identified by substitution analysis and/or subsequent database searches. Here, we have shown that two nonhomologous, endogenous peptides are recognized similarly by the same TCR. When either of the two allopeptides, p2Ca and dEV-8, are added to T2-Kb cells, the 2C T cells are induced to lyse the target cells. While this is true for Kb, the addition of p2Ca to Kbm3 or dEV-8 to Ld does not permit lysis of those targets. The fact that the structures of these two peptides presented in the context of Kb appears to be very different raises the possibility that the class I heavy chain itself may play an important role in the selection of receptors during development of the repertoire. In line with this view, we have recently demonstrated positive selection of 2C in the context of class I molecules expressed in the thymus of TAP-1-mice (manuscript in preparation).

Another point that emerges from these studies is that a single residue change on the class I molecule can alter substantially the recognition by a T cell. Kbm3 differs from the Kb molecule by only two amino acids at positions 77 and 89, (Asp->Ser and Lys->Ala, respectively). Amino acid position 89 is located on a loop and is not important for the recognition of Kbm3 by T cells, including 2C (36). Therefore, position 77 is solely responsible for the differential recognition of Kb and Kbm3. While SIYR-8 is highly antigenic when presented by either Kb or Kbm3, significant differences are observed in the ability of Kb and Kbm3 to present dEV-8 and p2Ca. A broader implication of these findings is that peptides that bind structurally related, but distinct, class I molecules induce different conformations, as visualized using mAb or molecular modeling. All five peptides analyzed conformed to this rule. This has far-reaching implications in regard to the positive selection of the T cell repertoire that is mediated by the presentation of self peptide in the thymus. A single amino acid substitution in an MHC molecule could thereby influence a substantial portion of the developing T cell repertoire, as the nature of TCR interactions with these altered conformations could result in fine specificity differences exemplified by dEV8 and p2Ca presentation by Kb and Kbm3.

Two of the peptides analyzed in this study, p2Ca and dEV-8, are from endogenous sources and have the potential of playing a role in selection of the 2C TCR. While we observe strong recognition in the context of high density presentation of these peptides by TAP-deficient target cells, normal cells expressing these peptides are not highly antigenic. The apparent low affinity/avidity of these complexes for the 2C TCR is consistent with the selection model that proposes that moderate affinity/avidity situations allow positive selection (2, 36). Therefore, as suggested previously (5, 14, 25), p2Ca and/or dEV-8 may play a role in selecting the 2C TCR. However, despite extensive efforts to assess the role of either peptide in positive selection of 2C thymocytes using fetal thymic organ culture, we have not been able to demonstrate such a relationship. Another group has suggested that many different peptides, including p2Ca, QL-9, and OVA-8, promote positive selection of 2C in FTOC, while other Kb binding peptides do not (37). These results are consistent with the possibility that another, yet undefined peptide or set of endogenous peptides is responsible for the selection of the 2C TCR. However, conclusions along this line should be viewed cautiously because the in vitro FTOC system may not provide the conditions necessary for the appropriate development of every transgenic TCR-bearing cell. The development of in vivo techniques may supply the necessary approach to tackle this question.

The ability of a T cell to interact with a variety of ligands may be beneficial to the effective immune response. We have shown that the 2C TCR has the capability of associating with three different peptides in the context of its restriction element, Kb. While this degeneracy exists for recognition of peptides in Kb, this same peptide degeneracy is not observed for the two alloantigens that 2C also recognizes. The most interesting feature of the recognition on Kb is that dEV-8 and SIYR-8 (identified independently) are structurally similar, while p2Ca has little in common with the former two peptides, either structurally or conformationally. This system illustrates a connectivity between self and antigenic peptides, and it will be interesting to see whether this is a general principle in T cell recognition.


    Acknowledgments
 
We thank Michael Hansen and Kathleen Allen for technical assistance, and Terri Felmlee for secretarial support.


    Footnotes
 
1 This work was supported by National Institutes of Health Grant R01AI28320. Back

2 Current address: Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024. Back

3 Address correspondence and reprint requests to Dr. Larry R. Pease, Department of Immunology, Mayo Clinic/Foundation, 200 First St. SW, Rochester, MN 55905. Back

4 Abbreviations used in this paper: MCF, mean channel fluorescence; rmsd, root-mean-square displacement; mLBP, mouse LPS binding protein; VSV-8, eight-residue vesicular stomatitis virus peptide. Back

Received for publication February 19, 1997. Accepted for publication July 22, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.[Medline]
  2. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H.-P. Pircher, R. M. Zinkernagel, S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651.[Medline]
  3. Sheil, J. M., M. J. Bevan, L. LeFrancois. 1987. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells. J. Immunol. 138:3654.[Abstract]
  4. Guimezanes, A., T. N. M. Schumacher, H. L. Ploegh, A.-M. Schmitt-Verhulst. 1992. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Eur. J. Immunol. 22:1651.[Medline]
  5. Tallquist, M. D., T. J. Yun, L. R. Pease. 1996. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184:1017.[Abstract/Free Full Text]
  6. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.[Medline]
  7. Nanda, N. K., K. K. Arzoo, H. M. Geysen, A. Sette, E. E. Sercarz. 1995. Recognition of multiple peptide cores by a single T cell receptor. J. Exp. Med. 182:531.[Abstract/Free Full Text]
  8. Davis, M. M., Y. Chien. 1993. Topology and affinity of T-cell receptor mediated recognition of peptide-MHC complexes. Curr. Opin. Immunol. 5:45.[Medline]
  9. Sykulev, Y., A. Brunmark, M. Jackson, R. J. Cohen, P. A. Peterson, H. N. Eisen. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1:15.[Medline]
  10. Fremont, D. H., M. Matsumura, E. A. Stura, P. A. Peterson, I. A. Wilson. 1992. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257:919.[Abstract/Free Full Text]
  11. Fremont, D. H., E. A. Stura, M. Matsumura, P. A. Peterson, I. A. Wilson. 1995. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92:2479.[Abstract/Free Full Text]
  12. Kranz, D. M., D. H. Sherman, M. V. Sitkovsky, M. S. Pasternack, H. N. Eisen. 1984. Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc. Natl. Acad. Sci. USA 81:573.[Abstract/Free Full Text]
  13. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, D. Y. Loh. 1988. b. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73.[Medline]
  14. Udaka, K., T. J. Tsomides, H. N. Eisen. 1992. A naturally occurring peptide is recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69:989.[Medline]
  15. Udaka, K., K.-H. Weismüller, S. Kienle, G. Jung, P. Walden. 1996. Self-MHC-restricted peptides restricted by an alloreactive T lymphocyte clone. J. Immunol. 157:670.[Abstract]
  16. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russel, D. Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271.[Medline]
  17. Pullen, J. K., H. D. Hunt, R. H. Horton, L. R. Pease. 1989. The functional significance of two amino acid polymorphisms in the antigen-presenting domain of class I MHC molecule: molecular dissection of Kbm3. J. Immunol. 143:1674.[Abstract]
  18. Stuber, W., J. Knolle, G. Briepohl. 1989. Synthesis of peptide amides by Fmoc solid-phase peptide synthesis and acid labile anchor groups. Int. J. Pept. Protein Res. 34:15.
  19. Hämmerling, G. J., E. Rusch, N. Tada, S. Kimura, U. Hämmerling. 1982. Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc Natl. Acad Sci. USA 79:4737.[Abstract/Free Full Text]
  20. Jones, T. A., J.-Y. Zou, S. W. Cowan, M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. A 47:110.
  21. Ponder, J. W., F. M. Richards. 1987. Tertiary templates for proteins: use of packing criteria in the enumeration of allowed sequences for different structural classes. J. Mol. Biol. 193:775.[Medline]
  22. Brünger, A. T.. 1992. A System for Crystallography and NMR Yale University Press, New Haven.
  23. Engh, R. A., R. Huber. 1991. Accurate bond and angle parameters for x-ray protein-structure refinement. Acta Cryst. A 47:392.
  24. Nicholls, A.. 1992. GRASP: Graphical Representation and Analysis of Surface Properties Columbia University, New York.
  25. Dutz, J. P., T. J. Tsomides, S. Kageyama, M. H. Rasmussen, H. N. Eisen. 1994. A cytotoxic T lymphocyte clone can recognize the same naturally occurring self peptide in association with a self and a nonself class I MHC protein. Mol. Immunol. 31:967.[Medline]
  26. Tallquist, M. D., L. R. Pease. 1995. Alloreactive 2C T cells recognize a self peptide in the context of the mutant Kbm3 molecule. J. Immunol. 155:2419.[Abstract]
  27. Rohren, E. M., L. R. Pease, H. L. Ploegh, T. N. M. Schumacher. 1993. Polymorphisms in pockets of major histocompatibility complex class I molecules influence peptide preference. J. Exp. Med. 177:1713.[Abstract/Free Full Text]
  28. Rohren, E. M., D. J. McCormick, L. R. Pease. 1994. Peptide-induced conformational changes in class I molecules: direct detection by flow cytometry. J. Immunol. 152:5337.[Abstract]
  29. Pease, L. R., R. M. Horton, J. K. Pullen, H. D. Hunt, T. J. Yun, E. M. Rohren, J. L. Prescott, S. M. Jobe, K. S. Allen. 1993. Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins. J. Immunol. 150:3375.[Abstract]
  30. Pullen, J. K., H. D. Hunt, L. R. Pease. 1991. Peptide interactions with the Kb antigen recognition site. J. Immunol. 146:2145.[Abstract]
  31. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.[Medline]
  32. Matsumura, M., D. H. Fremont, P. A. Peterson, I. A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.[Abstract/Free Full Text]
  33. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, I. A. Wilson. 1996. An {alpha}ß T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209.[Abstract/Free Full Text]
  34. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddiscon, D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.[Medline]
  35. Brock, R., K.-H. Wiesmüller, G. Jung, P. Walden. 1996. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc. Natl. Acad. Sci. USA 93:13108.[Abstract/Free Full Text]
  36. Alam, S. M., P. J. Travers, J. L. Wung, W. Nasholds, S. Redpath, S. C. Jameson, N. R. J. Gascoigne. 1996. T-cell receptor affinity and thymocyte positive selection. Nature 381:616.[Medline]
  37. Pawlowski, T. J., M. D. Singleton, D. Y. Loh, R. Berg, U. D. Staerz. 1996. Permissive recognition during positive selection. Eur. J. Immunol. 26:851.[Medline]



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Leng, Q. Ge, T. Nguyen, H. N. Eisen, and J. Chen
Stage-dependent reactivity of thymocytes to self-peptide-MHC complexes
PNAS, March 20, 2007; 104(12): 5038 - 5043.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Z. Yu, M. H. Albert, and C. Anasetti
Alloantigen Affinity and CD4 Help Determine Severity of Graft-versus-Host Disease Mediated by CD8 Donor T Cells
J. Immunol., March 15, 2006; 176(6): 3383 - 3390.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. J. Felix, A. Suri, J. J. Walters, S. Horvath, M. L. Gross, and P. M. Allen
I-Ep-Bound Self-Peptides: Identification, Characterization, and Role in Alloreactivity
J. Immunol., January 15, 2006; 176(2): 1062 - 1071.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. E. Whitelegg, L. E. M. Oosten, S. Jordan, M. Kester, A. G. S. van Halteren, J. A. Madrigal, E. Goulmy, and L. D. Barber
Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers
J. Immunol., August 1, 2005; 175(3): 1706 - 1714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Rudolph, L. Q. Shen, S. A. Lamontagne, J. G. Luz, J. R. Delaney, Q. Ge, B. K. Cho, D. Palliser, C. A. McKinley, J. Chen, et al.
A Peptide That Antagonizes TCR-Mediated Reactions with Both Syngeneic and Allogeneic Agonists: Functional and Structural Aspects
J. Immunol., March 1, 2004; 172(5): 2994 - 3002.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Y. L. Yu, N. Netuschil, L. Lybarger, J. M. Connolly, and T. H. Hansen
Cutting Edge: Single-Chain Trimers of MHC Class I Molecules Form Stable Structures That Potently Stimulate Antigen-Specific T Cells and B Cells
J. Immunol., April 1, 2002; 168(7): 3145 - 3149.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. C. Hornell, S. M. Martin, N. B. Myers, and J. M. Connolly
Peptide Length Variants p2Ca and QL9 Present Distinct Conformations to Ld-Specific T Cells
J. Immunol., October 15, 2001; 167(8): 4207 - 4214.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Maurice, D. S. Gould, J. Carroll, Y. Vugmeyster, and H. L. Ploegh
Positive selection of an MHC class-I restricted TCR in the absence of classical MHC class I molecules
PNAS, June 7, 2001; (2001) 141143298.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. J. Felix, W. J. Brickey, R. Griffiths, J. Zhang, L. Van Kaer, T. Coffman, and J. P.-Y. Ting
H2-DM{alpha}-/- Mice Show the Importance of Major Histocompatibility Complex-bound Peptide in Cardiac Allograft Rejection
J. Exp. Med., June 26, 2000; 192(1): 31 - 40.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Obst, N. Netuschil, K. Klopfer, S. Stevanovi, and H.-G. Rammensee
The Role of Peptides in T Cell Alloreactivity Is Determined by Self-Major Histocompatibility Complex Molecules
J. Exp. Med., March 6, 2000; 191(5): 805 - 812.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. T. Kuhns, M. D. Tallquist, A. J. Johnson, Y. Mendez-Fernandez, and L. R. Pease
T cell receptor interactions with class I heavy-chain influence T cell selection
PNAS, January 18, 2000; 97(2): 756 - 760.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Garcia-Peydro, A. Paradela, J. R. Lamas, and J. A. Lopez de Castro
Peptide Presentation to an Alloreactive CTL Clone Is Modulated Through Multiple Mechanisms Involving Polymorphic and Conserved Residues in HLA-B27
J. Immunol., December 1, 1999; 163(11): 6060 - 6064.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. C. Hornell, J. C. Solheim, N. B. Myers, W. E. Gillanders, G. K. Balendiran, T. H. Hansen, and J. M. Connolly
Alloreactive and Syngeneic CTL Are Comparably Dependent on Interaction with MHC Class I {alpha}-Helical Residues
J. Immunol., September 15, 1999; 163(6): 3217 - 3225.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Zhao, D. J. Loftus, E. Appella, and E. J. Collins
Structural Evidence of  T Cell Xeno-reactivity in the Absence of Molecular Mimicry
J. Exp. Med., January 18, 1999; 189(2): 359 - 370.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K. C. Garcia, M. Degano, L. R. Pease, M. Huang, P. A. Peterson, L. Teyton, and I. A. Wilson
Structural Basis of Plasticity in T Cell Receptor Recognition of a Self Peptide-MHC Antigen
Science, February 20, 1998; 279(5354): 1166 - 1172.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Maurice, D. S. Gould, J. Carroll, Y. Vugmeyster, and H. L. Ploegh
Positive selection of an MHC class-I restricted TCR in the absence of classical MHC class I molecules
PNAS, June 19, 2001; 98(13): 7437 - 7442.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. G. Luz, M. Huang, K. C. Garcia, M. G. Rudolph, V. Apostolopoulos, L. Teyton, and I. A. Wilson
Structural Comparison of Allogeneic and Syngeneic T Cell Receptor-Peptide-Major Histocompatibility Complex Complexes: A Buried Alloreactive Mutation Subtly Alters Peptide Presentation Substantially Increasing V{beta} Interactions
J. Exp. Med., May 6, 2002; 195(9): 1175 - 1186.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tallquist, M. D.
Right arrow Articles by Pease, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tallquist, M. D.
Right arrow Articles by Pease, L. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS